Intuitive Surgical Inc
ISRG: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| $841.00 | Wcqt | Wstbspfmv |
Intuitive Surgical Finally Set to Launch Next-Generation Platform in 2024
Business Strategy and Outlook
Intuitive Surgical continues to benefit from the ongoing global adoption of robotic surgery, even in the procedures we didn't view as likely to convert. Our long-term positive view about the company's competitive positioning is unchanged even as new competitors have finally arrived on the scene, and with the release of the next-generation platform, Intuitive should maintain its dominance.